26 results on '"Gerli, Roberto"'
Search Results
2. Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’
3. Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’
4. Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease
5. Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a ‘mix-and-match’ approach?
6. The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren’s syndrome
7. Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: beware of cell-to-cell contact
8. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium
9. The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans
10. A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis
11. A3.8 Association between clinical, histopathological and molecular features in primary Sjögren’s Syndrome: a retrospective study
12. A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome
13. Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study
14. The classification criteria for Sjögren syndrome: issues for their improvement from the study of a large Italian cohort of patients
15. A3.4 CD3+CD4–CD8–Double Negative Th17 Cells: New Insights in the Pathogenesis of Primary Sjögren’s Syndrome
16. A9.18 Potential Therapeutic Application of Human Umbilical Cord wharton Jelly Derived Mesenchymal Stem Cells in Primary Sjögren’s Syndrome
17. IL-17-producing CD4−CD8−T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjögren's syndrome
18. Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment
19. Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'.
20. Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'.
21. Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease.
22. Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a 'mix-and-match' approach?
23. The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren's syndrome.
24. Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: beware of cell-to-cell contact.
25. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.
26. IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.